Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Addict Biol. 2014 Dec 15;21(2):450–459. doi: 10.1111/adb.12207

Figure 2.

Figure 2

Mean daily self-efficacy to resist heavy drinking by medication and genotype groups. Among rs2832407*C homozygotes, topiramate treatment was associated with significantly greater self-efficacy than those receiving placebo (p < 0.001). There was no medication effect on confidence to resist heavy drinking in the rs2832407*A-allele carrier group (p=0.77).